Drug therapy: Use of diuretics in patients with hypertension

New England Journal of Medicine

Volumn 361, Issue 22, 2009, Pages

  Ernst, Michael E ^a,b   Moser, Marvin ^c  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMILORIDE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BENDROFLUMETHIAZIDE; CHLOROTHIAZIDE; CHLORTALIDONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOXAZOSIN; EPLERENONE; FUROSEMIDE; HYDROCHLOROTHIAZIDE; INDAPAMIDE; LISINOPRIL; LOOP DIURETIC AGENT; METHYCLOTHIAZIDE; METOLAZONE; NONSTEROID ANTIINFLAMMATORY AGENT; POLYTHIAZIDE; POTASSIUM CHLORIDE; POTASSIUM SPARING DIURETIC AGENT; SPIRONOLACTONE; SUNSCREEN; THIAZIDE DIURETIC AGENT; TORASEMIDE; TRIAMTERENE; ANTIHYPERTENSIVE AGENT;

ADD ON THERAPY; ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE REGULATION; BLOOD PRESSURE VARIABILITY; BREAST TENDERNESS; CARDIOVASCULAR DISEASE; CHEMICAL COMPOSITION; CLINICAL TRIAL; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIURETIC THERAPY; DIZZINESS; DOSE TIME EFFECT RELATION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DISTRIBUTION; DRUG DOSE REDUCTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG INDICATION; DRUG ISOLATION; DRUG MECHANISM; DRUG METABOLISM; DRUG POTENTIATION; DRUG PROTEIN BINDING; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EDEMA; ENZYME INHIBITION; GLYCEMIC CONTROL; GORDON SYNDROME; GOUT; GYNECOMASTIA; HEART FAILURE; HEART INFARCTION; HEART OUTPUT; HUMAN; HYPERKALEMIA; HYPERTENSION; HYPERVOLEMIA; HYPOKALEMIA; HYPONATREMIA; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; LOW DRUG DOSE; MONOTHERAPY; MUSCLE CRAMP; NEPHROTOXICITY; NOCTURIA; PHOTOSENSITIVITY; PLASMA VOLUME; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; URINARY EXCRETION; URINE INCONTINENCE; VASCULAR RESISTANCE; DRUG COMBINATION; DRUG EFFECT; DRUG INTERACTION; KIDNEY; METABOLISM;

ANTIHYPERTENSIVE AGENTS; DIURETICS; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; HUMANS; HYPERTENSION; KIDNEY; RENAL INSUFFICIENCY; SODIUM CHLORIDE SYMPORTER INHIBITORS;

EID: 72049116836     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMra0907219     Document Type: Review

References (84)

1. Freis ED, Wanko A, Wilson IM, Parrish AE. Treatment of essential hypertension with chlorothiazide (Diuril): its use alone and combined with other antihypertensive agents. J Am Med Assoc 1958;166: 137-140
2. Moser M, Macaulay AI. Chlorothiazide as an adjunct in the treatment of essential hypertension. Am J Cardiol 1959;3: 214-219
3. Southworth H. Acidosis associated with the administration of para-amino-benzene- sulfonamide (Prontylin). Proc Soc Exp Biol Med 1937;36:58-61.
4. Strauss MB, Southworth H. Urinary changes due to sulfonamide administration. Bull Johns Hopkins Hosp 1938;63: 41-5.
5. Novello FC, Sprague JM. Benzothiadiazine dioxides as novel diuretics. J Am Chem Soc 1957;79:2028-2029
6. Beyer KH Jr, Baer JE, Russo HF, Noll R. Electrolyte excretion as influenced by chlorothiazide. Science 1958;127:146-147
7. Ellison DH, Velázquez H, Wright FS. Thiazide-sensitive sodium chloride cotransport in early distal tubule. Am J Physiol 1987;253:F546-F554. (Pubitemid 18073154)
8. Beermann B, Groschinsky-Grind M. Clinical pharmacokinetics of diuretics. Clin Pharmacokinet 1980;5:221-245
9. Welling PG. Pharmacokinetics of the thiazide diuretics. Biopharm Drug Dispos 1986;7:501-535
10. Jackson EK. Diuretics. In: Brunton LL, Lazo JS, Parker KL, eds. Goodman & Gilman's the pharmacological basis of therapeutics. 11th ed. New York: McGraw-Hill, 2006:737-770
11. Hasannejad H, Takeda M, Taki K, et al. Interactions of human organic anion transporters with diuretics. J Pharmacol Exp Ther 2004;308:1021-1029 (Pubitemid 38263978)
12. Sica DA, Moser M. Diuretic therapy in cardiovascular disease. In Black HR, Elliott WJ, eds. Hypertension: a companion to Braunwald's heart disease. Philadelphia: W.B. Saunders, 2007.
13. Riess W, Dubach UC, Burckhardt D, Theobald W, Vuillard P, Zimmerli M. Pharmacokinetic studies with chlorthalidone (Hygroton) in man. Eur J Clin Pharmacol 1977;12:375-382 (Pubitemid 8246723)
14. Dieterle W, Wagner J, Faigle JW. Binding of chlorthalidone (Hygroton) to blood components in man. Eur J Clin Pharmacol 1976;10:37-42.
15. Temperini C, Cecchi A, Scozzafava A, Supuran CT. Carbonic anhydrase inhibitors: sulfonamide diuretics revisited - old leads for new applications? Org Biomol Chem 2008;6:2499-2506
16. Bengtsson C, Johnsson G, Sannerstedt R, Werkö L. Effect of different doses of chlorthalidone on blood pressure, serum potassium, and serum urate. Br Med J 1975;1:197-199
17. Lund-Johansenn P. Hemodynamic changes in long-term diuretic therapy of essential hypertension: a comparative study of chlorthalidone, polythiazide and hydrochlorothiazide. Acta Med Scand 1970;187: 509-518
18. Tarazi RC, Dustan HP, Frohlich ED. Long-term thiazide therapy in essential hypertension: evidence for persistent alterations in plasma volume and renin activity. Circulation 1970;41:709-717
19. Wilson IM, Freis ED. Relationship between plasma and extracellular fluid volume depletion and the antihypertensive effect of chlorothiazide. Circulation 1959; 20:1028-1036
20. Roos JC, Boer P, Koomans HA, Geyskes GG, Dorhout Mees EJ. Haemodynamic and hormonal changes during acute and chronic diuretic treatment in essential hypertension. Eur J Clin Pharmacol 1981;19: 107-112 (Pubitemid 11204237)
21. Gifford RW Jr, Mattox VR, Orvis AL, Sones DA, Rosevear JW. Effect of thiazide diuretics on plasma volume, body electrolytes, and excretion of aldosterone in hypertension. Circulation 1961;24:1197-1205
22. de Carvalho JG, Dunn FG, Lohmöller G, Frohlich ED. Hemodynamic correlates of prolonged thiazide therapy: comparison of responders and nonresponders. Clin Pharmacol Ther 1977;22:875-880
23. Shah S, Khatri I, Freis ED. Mechanism of antihypertensive effect of thiazide diuretics. Am Heart J 1978;95:611-618
24. Hughes AD. How do thiazide and thiazide-like diuretics lower blood pressure? J Renin Angiotensin Aldosterone Syst 2004;5:155-160
25. Finnerty FA Jr. Step-down treatment of mild systemic hypertension. Am J Cardiol 1984;53:1304-1307 (Pubitemid 14118872)
26. Stamler R, Stamler J, Grimm R, et al. Nutritional therapy for high blood pressure: final report of a four-year randomized controlled trial - the Hypertension Control Program. JAMA 1987;257:1484-1491 (Pubitemid 17070866)
27. Ellison DH. Diuretic resistance: physiology and therapeutics. Semin Nephrol 1999;19:581-597
28. Ram CV, Garrett BN, Kaplan NM. Moderate sodium restriction and various diuretics in the treatment of hypertension. Arch Intern Med 1981;141:1015-1019
29. Almeshari K, Ahlstrom NG, Capraro FE, Wilcox CS. A volume-independent component to post-diuretic sodium retention in humans. J Am Soc Nephrol 1993;3: 1878-1883
30. Ellison DH, Velázquez H, Wright FS. Adaptation of the distal convoluted tubule of the rat: structural and functional effects of dietary sodium intake and chronic diuretic infusion. J Clin Invest 1989;83: 113-126 (Pubitemid 19048413)
31. Kim GH. Long-term adaptation of renal ion transporters to chronic diuretic treatment. Am J Nephrol 2004;24:595-605.
32. Ellison DH. The physiologic basis of diuretic synergism: its role in treating diuretic resistance. Ann Intern Med 1991; 114:886-894
33. Taler SJ, Textor SC, Augustine JE. Resistant hypertension: comparing hemodynamic management to specialist care. Hypertension 2002;39:982-988
34. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991;265:3255-3264
35. Materson BJ, Reda DJ, Cushman WC, et al. Single-drug therapy for hypertension in men: a comparison of six antihypertensive agents with placebo. N Engl J Med 1993;328:914-921 [Erratum, N Engl J Med 1994;330:1689.]
36. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003;289: 2560-2572 [Erratum, JAMA 2003;290:197.]
37. Calhoun DA, Jones D, Textor S, et al. Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension 2008;51:1403-1419
38. Knauf H, Mutschler E. Diuretic effectiveness of hydrochlorothiazide and furosemide alone and in combination in chronic renal failure. J Cardiovasc Pharmacol 1995;26:394-400.
39. Dussol B, Moussi-Frances J, Morange S, Somma-Delpero C, Mundler O, Berland Y. A randomized trial of furosemide vs hydrochlorothiazide in patients with chronic renal failure and hypertension. Nephrol Dial Transplant 2005;20:349-353 (Pubitemid 40276891)
40. Paton RR, Kane RE. Long-term diuretic therapy with metolazone of renal failure and the nephrotic syndrome. J Clin Pharmacol 1977;17:243-251 (Pubitemid 8071319)
41. Finnerty FA Jr, Maxwell MH, Lunn J, Moser M. Long-term effects of furosemide and hydrochlorothiazide in patients with essential hypertension: a two-year comparison of efficacy and safety. Angiology 1977;28:125-133 (Pubitemid 8065265)
42. Saha C, Eckert GJ, Ambrosius WT, et al. Improvement in blood pressure with inhibition of the epithelial sodium channel in blacks with hypertension. Hypertension 2005;46:481-487 (Pubitemid 41376826)
43. Brater DC. Diuretic therapy. N Engl J Med 1998;339:387-395
44. Nishizaka MK, Zaman MA, Calhoun DA. Efficacy of low-dose spironolactone in subjects with resistant hypertension. Am J Hypertens 2003;16:925-930
45. Veterans Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension: results in patients with diastolic blood pressures averaging 115 through 129 mm Hg. JAMA 1967;202:1028-1034
46. Psaty BM, Lumley T, Furberg CD, et al. Health outcomes associated with various antihypertensive therapies used as firstline agents: a network meta-analysis. JAMA 2003;289:2534-2544 (Pubitemid 37430155)
47. Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: metaanalysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 2009;338: b1665.
48. Wright JM, Musini VM. First-line drugs for hypertension. Cochrane Database Syst Rev 2009;3:CD001841.
49. Turnbull F. Effects of different bloodpressure- lowering regimens on major cardiovascular events: results of prospectivelydesigned overviews of randomised trials. Lancet 2003;362:1527-1535 (Pubitemid 37410190)
50. Blood Pressure Lowering Treatment Trialists' Collaboration. Do men and women respond differently to blood pressurelowering treatment? Results of prospectively designed overviews of randomized trials. Eur Heart J 2008;29:2669-2680
51. Idem. Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials. BMJ 2008;336:1121-1123
52. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin- converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002;288:2981-2997 [Erratum, JAMA 2003;289:178, 2004;291: 2196.]
53. Whelton PK, Barzilay J, Cushman WC, et al. Clinical outcomes in antihypertensive treatment of type 2 diabetes, impaired fasting glucose concentration, and normoglycemia: Antihypertensive and Lipid- Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Arch Intern Med 2005;165:1401-1409 (Pubitemid 40973423)
54. Barzilay JI, Davis BR, Cutler JA, et al. Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Arch Intern Med 2006; 166:2191-2201
55. Wright JT Jr, Harris-Haywood S, Pressel S, et al. Clinical outcomes by race in hypertensive patients with and without the metabolic syndrome: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Arch Intern Med 2008;168:207-217 (Pubitemid 351185889)
56. Black HR, Davis B, Barzilay J, et al. Metabolic and clinical outcomes in nondiabetic individuals with the metabolic syndrome assigned to chlorthalidone, amlodipine, or lisinopril as initial treatment for hypertension: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Diabetes Care 2008;31:353-360 (Pubitemid 351213350)
57. Wright JT Jr, Probstfield JL, Cushman WC, et al. ALLHAT findings revisited in the context of subsequent analyses, other trials, and meta-analyses. Arch Intern Med 2009;169:832-842
58. Beckett NS, Peters R, Fletcher AE, et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med 2008;358:1887-1898 (Pubitemid 351620109)
59. Carter BL, Ernst ME, Cohen JD. Hydrochlorothiazide versus chlorthalidone: evidence supporting their interchangeability. Hypertension 2004;43:4-9.
60. Elliott WJ, Grimm RH Jr. Using diuretics in practice - one opinion. J Clin Hypertens (Greenwich) 2008;10:856-862
61. Wing LMH, Reid CM, Ryan P, et al. A comparison of outcomes with angiotensin- converting-enzyme inhibitors and diuretics for hypertension in the elderly. N Engl J Med 2003;348:583-592 (Pubitemid 36204952)
62. Jamerson K, Weber MA, Bakris GL, et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in highrisk patients. N Engl J Med 2008;359:2417-2428
63. Bowlus WE, Langford HG. A comparison of the antihypertensive effect of chlorthalidone and hydrochlorothiazide. Clin Pharmacol Ther 1964;5:708-711
64. Finnerty FA Jr. A double-blind study of chlorthalidone and hydrochlorothiazide in an outpatient population of moderate hypertensives. Angiology 1976;27: 738-744
65. Ernst ME, Carter BL, Goerdt CJ, et al. Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure. Hypertension 2006;47:352-358 (Pubitemid 43740274)
66. The Multiple Risk Factor Intervention Trial Research Group (MRFIT). Mortality after 10 years for hypertensive participants in the Multiple Risk Factor Intervention Trial. Circulation 1990;82:1616-1628
67. Psaty BM, Lumley T, Furberg CD. Meta-analysis of health outcomes of chlorthalidone- based vs nonchlorthalidone- based low-dose diuretic therapies. JAMA 2004;292:43-44 (Pubitemid 38923792)
68. Messerli FH, Bangalore S, Julius S. Risk/benefit assessment of beta-blockers and diuretics precludes their use for firstline therapy in hypertension. Circulation 2008;117:2706-2715
69. Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure: a cooperative study. JAMA 1977;237:255-261
70. National Collaborating Centre for Chronic Conditions. Hypertension: management in adults in primary care: pharmacological update. London: Royal College of Physicians, 2006.
71. Mancia G, De Backer G, Dominiczak A, et al. 2007 ESH-ESC practice guidelines for the management of arterial hypertension. J Hypertens 2007;25:1751-1762 [Erratum, J Hypertens 2007;25:2184.]
72. Muntner P, Krousel-Wood M, Hyre AD, et al. Antihypertensive prescriptions for newly treated patients before and after the main Antihypertensive and Lipid-lowering Treatment to Prevent Heart Attack Trial results and Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure guidelines. Hypertension 2009;53:617-623
73. Moser M. Why are physicians not prescribing diuretics more frequently in the management of hypertension? JAMA 1998; 279:1813-1816
74. Zhou MS, Schulman IH, Jaimes EA, Raij L. Thiazide diuretics, endothelial function, and vascular oxidative stress. J Hypertens 2008;26:494-500. (Pubitemid 351317258)
75. McInnes GT, Yeo WW, Ramsay LE, Moser M. Cardiotoxicity and diuretics: much speculation, little substance. J Hypertens 1992;10:317-335
76. Freis ED. The efficacy and safety of diuretics in treating hypertension. Ann Intern Med 1995;122:223-226
77. Grimm RH Jr, Grandits GA, Cutler JA, et al. Relationships of quality-of-life measures to long-term lifestyle and drug treatment in the Treatment of Mild Hypertension Study. Arch Intern Med 1997; 157:638-648
78. Cushman WC, Khatri I, Materson BJ, et al. Treatment of hypertension in the elderly. III. Response of isolated systolic hypertension to various doses of hydrochlorothiazide: results of a Department of Veterans Affairs cooperative study. Arch Intern Med 1991;151:1954-1960
79. Carter BL, Einhorn PT, Brands M, et al. Thiazide-induced dysglycemia: call for research from a working group from the National Heart, Lung, and Blood Institute. Hypertension 2008;52:30-36
80. Franse LV, Pahor M, Di Bari M, Somes GW, Cushman WC, Applegate WB. Hypokalemia associated with diuretic use and cardiovascular events in the Systolic Hypertension in the Elderly Program. Hypertension 2000;35:1025-1030 (Pubitemid 30327250)
81. Turnbull F, Neal B, Algert C, et al. Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials. Arch Intern Med 2005;165:1410-1419 (Pubitemid 40973424)
82. Curb JD, Pressel SL, Cutler JA, et al. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. JAMA 1996;276: 1886-1892 [Erratum, JAMA 1997;277:1356.]
83. Kostis JB, Wilson AC, Freudenberger RS, Cosgrove NM, Pressel SL, Davis BR. Long-term effect of diuretic-based therapy on fatal outcomes in subjects with isolated systolic hypertension with and without diabetes. Am J Cardiol 2005;95: 29-35.
84. Savage PJ, Pressel SL, Curb JD, et al. Influence of long-term, low-dose, diuretic- based, antihypertensive therapy on glucose, lipid, uric acid, and potassium levels in older men and women with isolated systolic hypertension: the Systolic Hypertension in the Elderly Program. Arch Intern Med 1998;158:741-751